Angeline Ginzac Couvé

10PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples theory of change models for healthPredictive and prognostic markersRadiation therapySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 07, 2026
Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol.

|Dec 20, 2025
Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial.

Angeline Ginzac, Emmanuelle Bourbouloux, Romain Rivoirard

|Mar 07, 2024
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.

Angeline Ginzac, Ioana Molnar, Xavier Durando

|Jul 03, 2023
Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial.

Angeline Ginzac, Marie-Céleste Ferreira, Anne Cayre

|Aug 18, 2021
Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study.

Tressie Herrmann, Angeline Ginzac, Ioana Molnar

|Jul 29, 2021
Preoperative stereotactic radiosurgery for brain metastases: the STEP study protocol for a multicentre, prospective, phase-II trial.

Angeline Ginzac, Guillaume Dupic, Lucie Brun

Pageof 2

Frequent Collaborators

5 joint publications

Xavier Durando

4 joint publications

Ioana Molnar

2 joint publications

Maureen Bernadach

2 joint publications

Julian Biau